Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?-Reference-Cited by-同舟云学术

Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?

Published:2021-06 Issue: Volume:202 Page:134-138
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Skeith Leslie,Le Gal Grégoire,Rodger Marc A.

Funder

CSL Behring

Heart and Stroke Foundation of Canada

Publisher

Elsevier BV

Subject

Hematology

Reference51 articles.

1. Antithrombotic therapy for VTE disease;Kearon;Chest.,2016

2. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH;Kearon;J. Thromb. Haemost.,2016

3. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study;Rodger;BMJ,2017

4. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study;Le Moigne;Thromb. Res.,2013

5. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy;Rodger;CMAJ.,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Modified Bricks Ferrihydrite-Coated for the Elimination of Hormones from Contaminated Water: Case of 17α-Ethynylestradiol, Testosterone and Estrone;Chemistry Africa;2024-03-05

2. A practice tool for initiating and managing combined hormonal contraceptives for contraception: Assessment, decision-making and monitoring;Canadian Pharmacists Journal / Revue des Pharmaciens du Canada;2023-12-08

3. Where sports performance meets reproductive rights: hormonal contraception;Drugs: Education, Prevention and Policy;2023-09-24

4. Network analysis and experimental approach to investigate the potential therapeutic mechanism of zishen yutai pills on premature ovarian insufficiency;Heliyon;2023-09

5. Hormone replacement therapy does not increase thrombosis risk following THA: a national database study;Journal of Experimental Orthopaedics;2023-06-01